13F reference period
Q3 2026
Security Snapshot
Perspective Therapeutics, Inc. - Common Stock, $0.001 par value (CATX) Institutional Ownership
CUSIP: 46489V302
13F Institutional Holders and Ownership History from Q2 2024 to Q3 2026
Institutions Reporting
51
Shares (Excl. Options)
28.3M
Full value: 28,303,999 · shares · 30 Sep 2026Price
$2.75
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value
- Symbol
- CATX on NYSE
- All holders as of 30 Sep 2026
- Q3 2026
- Total 13F shares
- 28,303,999
- Total 13F value
- $77,835,625
- Portfolio coverage rank
- 0%
- Share change
- -4,137,172
- Value change
- -$11,596,598
- Number of holders
- 51
- Shares outstanding
- 121,513,103
- SEC-reported price per share
- $2.52
- Insider filing price
- $2.52
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- CATX - Perspective Therapeutics, Inc. - Common Stock, $0.001 par value is tracked under CUSIP 46489V302.
- 51 institutions reported positions in Q3 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 129 to 51 between Q2 2026 and Q3 2026.
- SEC-reported value moved from to
$296.71M
Full value: $296,707,183 · USD · 30 Jun 2026.$77.84M
Full value: $77,835,625 · USD · 30 Sep 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 51 institutions filings for Q3 2026.
Security key
46489V302
13F reference period
Q3 2026
13F holders
51
13D/G owners
11
CIK / CUSIP context first
Open Q3 2026 holders
CATX full holder history
Perspective Therapeutics, Inc. SEC filings
Perspective Therapeutics, Inc. company facts
Perspective Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 46489V302:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
CATX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Commodore Capital LP | 9.9% | $29,968,780 | 11,939,753 | Commodore Capital LP | 02 Feb 2026 | |||
| TCG Crossover GP II, LLC | 6.9% | $21,767,809 | 7,915,567 | Chen Yu | 03 Feb 2026 | |||
| BlackRock, Inc. | 6.8% | +44% | $26,519,365 | +$8,612,218 | 7,776,940 | +48% | BlackRock, Inc. | 30 Jun 2026 |
| Qatar Investment Authority | 6.2% | $19,451,597 | 7,073,308 | Qatar Investment Authority | 04 Feb 2026 | |||
| MILLENNIUM MANAGEMENT LLC | 5.5% | +4% | $21,413,088 | +$947,661 | 6,316,545 | +4.6% | Millennium Management LLC | 07 Aug 2026 |
| Avidity Partners Management LP | 5.3% | +28% | $29,523,995 | +$15,659,798 | 6,049,999 | +113% | Avidity Partners Management LP | 20 Feb 2026 |
| Lantheus Holdings, Inc. | 3.9% | -48% | $11,942,308 | -$10,080,000 | 4,739,011 | -46% | Lantheus Holdings, Inc. | 10 Nov 2026 |
| MORGAN STANLEY | 2.6% | -57% | $13,080,088 | -$6,641,479 | 2,959,296 | -34% | Morgan Stanley | 31 Mar 2026 |
| STATE STREET CORP | 1.8% | -70% | $5,108,017 | -$10,142,446 | 2,026,991 | -67% | STATE STREET CORPORATION | 30 Sep 2026 |
| FMR LLC | 0.4% | -98% | $824,113 | -$15,183,078 | 312,164 | -95% | FMR LLC | 28 Nov 2025 |
| JANUS HENDERSON GROUP PLC | 0% | $43,349 | 17,839 | JANUS HENDERSON GROUP PLC | 31 Dec 2024 |
As of 30 Sep 2026,
51
institutional investors reported holding
shares of
Perspective Therapeutics, Inc. - Common Stock, $0.001 par value (CATX).
This represents
23%
of the company’s total
outstanding shares.
28.3M
Full value: 28,303,999 · shares · 30 Sep 2026121.51M
Full value: 121,513,103 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
23%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 4,407,246 | -0.66% | 0% | $12,119,927 |
| Affinity Asset Advisors, LLC | 3.3% | 3,988,744 | -5.4% | 0.62% | $10,969,046 |
| Spruce Street Capital LP | 3% | 3,693,931 | 0% | 1.6% | $10,158,310 |
| Nantahala Capital Management, LLC | 2.1% | 2,492,642 | +7.2% | 0.39% | $6,854,766 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 2,037,352 | -17% | 0% | $5,604,311 |
| STATE STREET CORP | 1.7% | 2,026,991 | -67% | 0% | $5,574,225 |
| Nicholson Wealth Management Group, LLC | 1.3% | 1,618,993 | -0.06% | 2.7% | $4,452,231 |
| MARSHALL WACE, LLP | 1.2% | 1,481,991 | 0% | $4,075,477 | |
| DIMENSIONAL FUND ADVISORS LP | 1% | 1,227,846 | +14% | 0% | $3,374,931 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.81% | 986,459 | -9.3% | 0% | $2,712,762 |
| Hills Bank & Trust Co | 0.72% | 872,200 | 0% | 0.1% | $2,398,550 |
| MORGAN STANLEY | 0.51% | 624,200 | -67% | 0% | $1,716,551 |
| VANGUARD FIDUCIARY TRUST CO | 0.5% | 603,036 | +2.4% | 0% | $1,658,349 |
| WealthPlan Investment Management, LLC | 0.33% | 404,071 | 0% | 0.05% | $1,111,195 |
| FEDERATED HERMES, INC. | 0.19% | 227,112 | +4.6% | 0% | $624,558 |
| RENAISSANCE TECHNOLOGIES LLC | 0.18% | 221,633 | +275% | 0% | $609,491 |
| BNP PARIBAS FINANCIAL MARKETS | 0.18% | 220,280 | 0% | $605,770 | |
| AMERICAN CENTURY COMPANIES INC | 0.12% | 147,277 | +22% | 0% | $405,012 |
| Empowered Funds, LLC | 0.1% | 122,894 | 0% | $337,959 | |
| Trueblood Wealth Management, LLC | 0.08% | 99,740 | 0% | 0.1% | $274,285 |
| DEUTSCHE BANK AG\ | 0.07% | 88,126 | -13% | 0% | $242,347 |
| Taylor & Morgan Wealth Management, LLC | 0.07% | 86,000 | +30% | 0.11% | $236,500 |
| PANAGORA ASSET MANAGEMENT INC | 0.07% | 80,023 | 0% | $220,063 | |
| Creative Planning | 0.05% | 64,526 | +38% | 0% | $177,447 |
| PERKINS CAPITAL MANAGEMENT INC | 0.04% | 51,200 | +181% | 0.1% | $140,800 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Headline period
Q3 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 28,303,999 | $77,835,625 | -$11,596,598 | $2.75 | 51 |
| 2026 Q2 | 86,980,004 | $296,707,183 | +$22,274,936 | $3.41 | 129 |
| 2026 Q1 | 78,563,691 | $327,483,394 | +$156,403,502 | $4.17 | 136 |
| 2025 Q4 | 35,179,307 | $96,743,275 | -$20,013,129 | $2.75 | 114 |
| 2025 Q3 | 42,524,179 | $145,860,657 | +$1,461,871 | $3.43 | 103 |
| 2025 Q2 | 42,232,957 | $145,284,060 | +$679,387 | $3.44 | 95 |
| 2025 Q1 | 44,107,303 | $93,948,628 | -$10,507,953 | $2.13 | 109 |
| 2024 Q4 | 47,101,393 | $150,249,113 | -$74,925,753 | $3.19 | 133 |
| 2024 Q3 | 49,033,906 | $653,981,361 | +$116,633,428 | $13.35 | 124 |
| 2024 Q2 | 38,531,736 | $384,149,816 | +$383,863,185 | $9.97 | 102 |